The implantable cardioverter defibrillator: Indications and follow-up

La Tunisie Medicale
|March 2, 2018
PubMed

Insights

Sudden cardiac death is often caused by ventricular arrhythmias, treatable with implantable cardioverter defibrillators (ICDs). This study reports on ICD implantation outcomes, finding results comparable to major studies.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Sudden cardiac death (SCD) is a significant public health issue, primarily resulting from ventricular arrhythmias.
  • The implantable cardioverter defibrillator (ICD) is the established treatment for preventing SCD.

Purpose of the Study:

  • To review indications for ICD implantation based on underlying heart conditions.
  • To evaluate the short- and long-term outcomes of ICD implantation.

Main Methods:

  • A retrospective, descriptive study of 90 patients who received ICDs between January 2003 and December 2014.
  • Analysis of patient demographics, underlying heart diseases, ICD types, and procedural/follow-up outcomes.

Main Results:

  • Ischemic heart disease was the most frequent underlying condition (37%).
  • Primary prevention accounted for 52% of implantations.
  • Complications occurred in 10% early and 23% during follow-up, with inappropriate shocks being most common (12%).
  • Secondary prevention indication was a predictor of appropriate ICD therapies (p=0.002).
  • Ischemic heart disease and secondary prevention were associated with inappropriate shocks.

Conclusions:

  • ICD implantation outcomes in this series were comparable to major international studies and registries.
  • The study highlights the safety and efficacy of ICDs in managing ventricular arrhythmias and preventing SCD.
  • Understanding predictors of appropriate and inappropriate therapies can optimize patient selection and device programming.
Abstract

Related Concept Videos

Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
61.1K
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.9K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.8K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
4